Literature DB >> 18177801

Initial surgical management of thyroid cancer.

Robert L Witt1.   

Abstract

The rapid increase in the rate of papillary thyroid cancer is likely caused by improved surveillance. A significant trend toward total thyroidectomy for low-risk differentiated thyroid cancer is present in the United States after a paradigm shift from treatment of macroscopic disease to the treatment of macroscopic and microscopic disease by increasingly sensitive tests. Compelling arguments for thyroid lobectomy and total thyroidectomy for low-risk thyroid cancer remain. The relatively small number of deaths from thyroid cancer, the small number of clinical thyroid cancers, and the huge number of incidental thyroid cancers are indicative of how little we understand the biology of this disease. Clinical medicine awaits biologic markers to refine treatment recommendations.

Entities:  

Mesh:

Year:  2008        PMID: 18177801     DOI: 10.1016/j.soc.2007.10.010

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  8 in total

1.  Mass in the neck after radiation exposure from Chernobyl disaster.

Authors:  John C O'Brien; S Michelle Shiller; Matthew G Cusick; Baron L Hamman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-04

2.  BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Fei Li; Guangqi Chen; Chunjun Sheng; Aaron M Gusdon; Yueye Huang; Zhongwei Lv; Huixiong Xu; Mingzhao Xing; Shen Qu
Journal:  Endocr Relat Cancer       Date:  2015-01-15       Impact factor: 5.678

Review 3.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

4.  BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management.

Authors:  Mingzhao Xing
Journal:  Ann Surg Oncol       Date:  2009-01-22       Impact factor: 5.344

5.  BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.

Authors:  Mingzhao Xing; Douglas Clark; Haixia Guan; Meiju Ji; Alan Dackiw; Kathryn A Carson; Matthew Kim; Anthony Tufaro; Paul Ladenson; Martha Zeiger; Ralph Tufano
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

6.  Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer.

Authors:  Indira Prabakaran; Jillian R Grau; Robert Lewis; Douglas L Fraker; Marina A Guvakova
Journal:  J Thyroid Res       Date:  2011-10-20

7.  Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma.

Authors:  Guoping He; Baojian Zhao; Xu Zhang; Rixiang Gong
Journal:  Oncol Lett       Date:  2013-11-29       Impact factor: 2.967

8.  Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe.

Authors:  Sang Gab Yoon; Jin Wook Yi; Chan-Yong Seong; Jong-Kyu Kim; Su-Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee
Journal:  Ann Surg Treat Res       Date:  2017-02-24       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.